Page last updated: 2024-08-21

isoxazoles and Uterine Cervical Neoplasms

isoxazoles has been researched along with Uterine Cervical Neoplasms in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's2 (50.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Altwerger, G; Andikyan, V; Azodi, M; Bellone, S; Bonazzoli, E; Gnutti, B; Guglielmi, A; Han, C; Huang, GS; Manara, P; Menderes, G; Nagarkatti, N; Pelligra, S; Ratner, E; Santin, AD; Schwartz, PE; Silasi, DA; Tymon-Rosario, J; Zammataro, L; Zeybek, B1
Du, J; Lou, G; Luan, J; Ma, W; Wang, K1
Araki, K; Kamide, D; Shiotani, A; Shiozawa, S; Tanaka, S; Tanaka, Y; Tomifuji, M; Yamashita, T1
Hedley, DW; Ruoso, P1

Trials

1 trial(s) available for isoxazoles and Uterine Cervical Neoplasms

ArticleYear
Multi-dose parecoxib provides an immunoprotective effect by balancing T helper 1 (Th1), Th2, Th17 and regulatory T cytokines following laparoscopy in patients with cervical cancer.
    Molecular medicine reports, 2015, Volume: 11, Issue:4

    Topics: Adult; Aged; Analgesics; Cytokines; Female; Hospitalization; Humans; Isoxazoles; Laparoscopy; Middle Aged; Neoplasm Staging; Pain Measurement; Pain, Postoperative; RNA, Messenger; T-Lymphocytes, Helper-Inducer; T-Lymphocytes, Regulatory; Th1 Cells; Th17 Cells; Th2 Cells; Uterine Cervical Neoplasms

2015

Other Studies

3 other study(ies) available for isoxazoles and Uterine Cervical Neoplasms

ArticleYear
Derangements in HUWE1/c-MYC pathway confer sensitivity to the BET bromodomain inhibitor GS-626510 in uterine cervical carcinoma.
    Gynecologic oncology, 2020, Volume: 158, Issue:3

    Topics: Adult; Aged; Animals; Cell Line, Tumor; Female; Humans; Imidazoles; In Situ Hybridization, Fluorescence; Isoxazoles; Mice; Middle Aged; Proteins; Proto-Oncogene Proteins c-myc; Signal Transduction; Tumor Suppressor Proteins; Ubiquitin-Protein Ligases; Uterine Cervical Neoplasms; Xenograft Model Antitumor Assays; Young Adult

2020
Selective activator protein-1 inhibitor T-5224 prevents lymph node metastasis in an oral cancer model.
    Cancer science, 2016, Volume: 107, Issue:5

    Topics: Animals; Benzophenones; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Shape; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Humans; Isoxazoles; Lymphatic Metastasis; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice; Mice, Inbred BALB C; Mouth Neoplasms; Neoplasm Invasiveness; Transcription Factor AP-1; Uterine Cervical Neoplasms; Xenograft Model Antitumor Assays

2016
Inhibition of gamma-glutamyl transpeptidase activity decreases intracellular cysteine levels in cervical carcinoma.
    Cancer chemotherapy and pharmacology, 2004, Volume: 54, Issue:1

    Topics: Animals; Carcinoma, Squamous Cell; Cell Line, Tumor; Cysteine; Enzyme Inhibitors; Female; gamma-Glutamyltransferase; Humans; Isoxazoles; Mice; Mice, SCID; Transplantation, Heterologous; Uterine Cervical Neoplasms

2004